BackPOINT Biopharma Global Overview
POINT Biopharma Global Inc

POINT Biopharma Global PEG Ratio

Valuation check: PNT's PEG ratio is 379.12, above the Healthcare sector average of 11.64.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

379.12

PEG Ratio

379.12

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

POINT Biopharma Global (PNT) FAQ

As of the most recent data, PNT shows a PEG ratio of 379.12. That is above the Healthcare sector average of 11.64. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 11.64. POINT Biopharma Global is at 379.12, which is higher that average. That is roughly 3156.8% above the sector mean. Use the comparison chart on this page to see how PNT stacks up against individual peers as well.

Investors watch PNT's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. POINT Biopharma Global's latest reading is 379.12. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has POINT Biopharma Global's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 379.12) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 11.64, while PNT is at 379.12. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.